Category: Comparative Effectiveness Research

June 22, 2017

Senior Patient and Family Caregiver Network Holds First Advocate Mentor Training

On May 23 and 24 in Washington, D.C., the Senior Patient and Family Caregiver Network held its first-ever training session for its patient and family caregiver advocates. 
October 27, 2016

Alliance for Aging Research Approved for a Eugene Washington Engagement Award by the Patient-Centered Outcomes Research Institute

The Alliance for Aging Research (Alliance) announced today that it has been approved for a $250,000 Eugene Washington PCORI Engagement Award to create a first-ever Senior Patient and Family Caregiver Network (SP&FCN) by the Patient-Centered Outcomes Research Institute (PCORI). 
August 14, 2015

Letter to NIH Director Collins Regarding RFI Inviting Comments and Suggestions on a Framework for the NIH-Wide Strategic Plan

This is a response from the Alliance to a Request for Information (RFI) Inviting Comments and Suggestions on a Framework for the NIH-wide Strategic Plan from NIH Director Dr. Francis Collins.
May 23, 2014

CER for More Patient-Centered Care

There is increasing emphasis on shaping a system that makes optimal patient outcomes a priority. The Alliance has been paying close attention to Patient-Centered Outcomes Research Institute’s (PCORI) initial work to provide information on which treatments and technologies deliver the best results. 
January 30, 2012

Challenges and Opportunities for PCORI and CER

In a time of skyrocketing health care costs, both the private and public sectors struggle to balance economics with access to high quality health care. Evidence from comparative effectiveness research (CER) and “head-to-head” clinical trials is increasingly being used in health care treatment decision-making around the globe, but how will this affect access to quality care? More importantly, where will the public draw the line between cost and access?
December 15, 2011

Moving Along the Guiderails with CER

In a time where health care spending is sky-rocketing, where will the public draw the line? Evidence from comparative effectiveness research (CER) is increasingly being used in health-care treatment decision-making around the globe, yet there is still a lot to be learned about how the public feels and where they think the lines should be drawn.